Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.95 +0.00 (+0.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Selling, General & Administrative (2016 - 2026)

Updated

Creative Medical Technology Holdings (CELZ) recorded Selling, General & Administrative of $1.08 million in Q2 2026, up 47.6% from $731,517 a year earlier and up 21.5% from the prior quarter.

Analysis

Creative Medical Technology Holdings (CELZ) Selling, General & Administrative (2016 - 2026) Analysis & Trends

On a TTM basis, Creative Medical Technology Holdings' Selling, General & Administrative came in at $4.11 million as of Jun 30, 2026, up 17.1% year-over-year; for FY2025, it came in at $3.76 million, up 16.2% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $3.24 million in FY2024 (-9.0%), $3.56 million in FY2023 (-9.7%), $3.94 million in FY2022 (+33.0%) and $2.96 million in FY2021 (+155.1%).
  • Quarterly Selling, General & Administrative has ranged from $498,607 in Q3 2024 to $1.43 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in four of the last eight quarters, with growth averaging 16.9%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 352.2% in Q4 2021, against a decline of 37.0% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $888,640 (Q1 2026), $1.37 million (Q4 2025) and $776,821 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Creative Medical Technology Holdings 1.25 Mn 1.27 Mn - 1.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Mn
Mar 31, 2026 888,640.00
Dec 31, 2025 1.37 Mn
Sep 30, 2025 776,821.00
Jun 30, 2025 731,517.00
Mar 31, 2025 888,397.00
Dec 31, 2024 1.39 Mn
Sep 30, 2024 498,607.00
Jun 30, 2024 676,086.00
Mar 31, 2024 671,484.00
Dec 31, 2023 1.40 Mn
Sep 30, 2023 531,042.00
Jun 30, 2023 859,537.00
Mar 31, 2023 771,020.00
Dec 31, 2022 899,597.00
Sep 30, 2022 805,461.00
Jun 30, 2022 1.11 Mn
Mar 31, 2022 1.13 Mn
Dec 31, 2021 1.43 Mn
Sep 30, 2021 757,235.00
API Access

Creative Medical Technology Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CELZ&period=max&api_key=YOUR_API_KEY